William Martin

William M. is the Chief Operating Officer and co-founder of Core Biotherapeutics, where William is focused on developing a new generation of drugs to treat complex pathological gene regulatory networks in diseases such as cancer, neurodegenerative, fibrotic, and cardiovascular diseases. With a background in corporate development and operations, William has also worked at companies like WKM Consulting, Exalys Therapeutics, Adynxx, and Corthera. William holds an MBA from MIT Sloan School of Management and a BA in Engineering and Economics from Dartmouth College.